Study guide

12.2 Case Review: Synthesizing Data, Outliers & Prognosis

Certified Wound Specialist Physician CWSP

Track your progress as you read

Finished sections get a check mark.

1 Introduction

About the CWSP Exam

2 Chapter 1: Integumentary Anatomy & Wound Healing Biology

1.1 Skin Anatomy, Microstructure & Epidermal-Dermal Barrier Function 1.2 Acute vs Chronic Wound Healing Phases & Cellular Kinetics 1.3 Extracellular Matrix Composition, Collagen Architecture & MMP Regulation

3 Chapter 2: Musculoskeletal & Neurologic Anatomy

2.1 Musculoskeletal Anatomy of the Leg & Foot 2.2 Neuroanatomy & Nerve Physiology for Wound Care

4 Chapter 3: Cell Signaling, Biofilm & Barriers to Healing

3.1 Growth Factors, Cytokines & Angiogenic Pathways 3.2 Biofilm Microbiology, Quorum Sensing & Phenotypic Resistance 3.3 Cellular Senescence, Hypoxia & Inflammatory Arrest 3.4 Metabolic, Steroid & Nutritional Impairments in Wound Healing

5 Chapter 4: Patient Evaluation & Vascular Diagnostics

4.1 Comprehensive Patient & Periwound Physical Examination 4.2 Noninvasive Macrovascular Hemodynamics: ABI, TBI & Segmental Pressures 4.3 Microvascular Perfusion Diagnostics: TcPO2, SPP & Near-Infrared Spectroscopy 4.4 Diagnostic Angiography, Duplex Ultrasonography & Angiosome Concepts

6 Chapter 5: Pain, Risk, Functional & Nutrition Assessment

5.1 Wound Pain Assessment 5.2 Risk Assessment Tools & Risk Stratification 5.3 Functional & Cognitive Assessment 5.4 Nutrition Screening & Assessment

7 Chapter 6: Imaging, Biopsy, Atypical Wounds & Neuropathy

6.1 Musculoskeletal Imaging for Osteomyelitis & Deep Space Infections 6.2 Diagnostic Tissue Biopsy, Culture Techniques & Quantitative Microbiology 6.3 Diagnostic Differential of Atypical & Malignant Ulcerations 6.4 Comprehensive Diabetic Peripheral Neuropathy & Biomechanical Assessment

8 Chapter 7: Wound Bed Preparation, Debridement, Dressings & Topical Agents

7.1 TIME Principle & Wound Bed Preparation Framework 7.2 Surgical, Sharp, Enzymatic, Autolytic & Biosurgical Debridement Modalities 7.3 Advanced Wound Dressings, Exudate Control & Moisture Balance 7.4 Topical Agents: Antiseptics, Antibiotics & Active Topicals

9 Chapter 8: Cellular & Tissue-Based Products, NPWT & Hyperbaric Oxygen

8.1 Cellular, Acellular & Matrix-Like Advanced Biologics (CTPs) 8.2 Negative Pressure Wound Therapy (NPWT) & Instillation Protocols 8.3 Hyperbaric Oxygen Therapy (HBOT): Mechanisms, Indications & Safety

10 Chapter 9: Biophysical Technologies: Electrical Stimulation & Ultrasound

9.1 Electrical Stimulation for Wound Healing 9.2 Therapeutic Ultrasound in Wound Care

11 Chapter 10: Revascularization, Antimicrobial Stewardship & Offloading

10.1 Revascularization for Limb Salvage 10.2 Systemic Antimicrobial Stewardship & Deep Infection Management 10.3 Mechanical Offloading, Pressure Redistribution & Total Contact Casting

12 Chapter 11: Surgical Closure & Healing Complications

11.1 Surgical Closure, Skin Grafts, Flaps & Amputation Levels 11.2 Managing Complications: Bleeding, Allergy, Adverse Events & Scarring

13 Chapter 12: Nutrition Therapy & Case Review

12.1 Nutrition Therapy for Wound Healing 12.2 Case Review: Synthesizing Data, Outliers & Prognosis

14 Chapter 13: Diabetic & Ischemic Lower-Extremity Wounds

13.1 Diabetic Foot Ulcers: Pathophysiology, Staging & Limb Salvage 13.2 Peripheral Arterial Disease & Ischemic Extremity Ulcerations 13.3 Mixed Arterial-Venous Disease & Complex Diagnostic Dilemmas

15 Chapter 14: Venous Disease, Pressure Injuries, Lymphedema & Edema

14.1 Venous Leg Ulcers, Chronic Venous Insufficiency & Compression 14.2 Pressure Injuries: NPIAP Staging, DTPI & Prevention 14.3 Lymphedema, Phlebolymphedema & Complete Decongestive Therapy 14.4 Edema: Systemic vs. Local Causes

16 Chapter 15: Inflammatory, Calcific, Medication-Induced & Dermatologic Wounds

15.1 Autoimmune & Inflammatory Ulcerations: Pyoderma Gangrenosum & Vasculitis 15.2 Calciphylaxis & Radiation Tissue Injury 15.3 Medication-Induced & Hematologic Atypical Wounds 15.4 Dermatologic Conditions That Cause or Complicate Wounds

17 Chapter 16: Traumatic Wounds, Burns & Frostbite

16.1 Traumatic Wounds: Lacerations, Bites, Degloving & Open Fractures 16.2 Thermal Burns & Frostbite

18 Chapter 17: Surgical, Infectious & Pediatric Wounds

17.1 Surgical Wounds, Surgical Site Infection & Dehiscence 17.2 Infectious Causes of Wounds: Necrotizing, Mycobacterial, Fungal & Other Infections 17.3 Pediatric Wound Care

19 Chapter 18: Reimbursement, Regulation & Documentation

18.1 CPT Coding, Modifiers & Documentation for Debridement and Biologics 18.2 Regulatory Compliance, CMS Quality Programs & Hospital-Acquired Conditions 18.3 Documentation, Legal Concepts & Confidentiality

20 Chapter 19: Ethics, Adherence, Epidemiology & Evidence-Based Practice

19.1 Clinical Ethics, Informed Consent & Palliative Wound Management 19.2 Patient Adherence & Psychosocial Care 19.3 Epidemiology of Chronic Wounds 19.4 Research Literacy, Evidence-Based Medicine & Quality Improvement

12.2 Case Review: Synthesizing Data, Outliers & Prognosis

Key Takeaways Explain This Topic AI

Case review follows a repeatable sequence: confirm the etiology, find every barrier to healing (perfusion, infection, pressure, edema, nutrition, glycemia, medications, adherence), set a prognosis, choose treatment and level of care, and set a date to measure progress.

Outliers deserve a second look: an ankle-brachial index above 1.3 to 1.4 with monophasic waveforms suggests calcified vessels and calls for toe pressures, and a normal white blood cell count or absent fever does not exclude serious diabetic foot infection.

When several poor prognostic markers occur together, such as severe ischemia, very low albumin from illness, uncontrolled diabetes, and infection, the chance of healing without correcting the dominant barrier is low, and severe ischemia usually has to be addressed first.

A wound that has not reduced in area by roughly 40% to 50% after 4 weeks of good care should trigger reassessment, and a wound that does not heal despite appropriate care (commonly by about 3 months) or looks atypical should be biopsied.

Level of care depends on severity: severe infection, sepsis, acute or critical ischemia needing urgent revascularization, and inability to manage safely at home favor admission, while stable wounds with support are managed as outpatients.

Last updated: September 2026

12.2 Case Review: Synthesizing Data, Outliers & Prognosis

Core Clinical Principle: Real patients rarely have one problem. Case review means pulling scattered data into one picture, deciding which barrier matters most, spotting results that do not fit, and turning the analysis into a plan with a clear checkpoint.

The CWSP outline lists case review, including analyzing laboratory and imaging results, outliers, prognosis, and synthesis of data, in Patient Management. Many exam items present a scenario with several data points and ask for the most important finding or the best next step.

A Structured Case Review

  • Step Questions to Answer Typical Data
  • 1. Etiology What caused the wound? Is there more than one cause? History, location, appearance, pain pattern
  • 2. Perfusion Is blood flow adequate to heal? Pulses, ABI, toe pressure or TBI, TcPO2, waveforms, imaging

3. Infection Is there local infection, spreading infection, or osteomyelitis? Clinical signs, probe-to-bone, ESR, CRP, WBC, radiographs, MRI, bone biopsy

4. Mechanical forces Is pressure, shear, or friction being relieved? Wound location, footwear, support surfaces, adherence

5. Edema Is swelling slowing healing? Exam, venous duplex, heart and kidney status

6. Host factors Are diabetes, nutrition, kidney disease, medications, or smoking impairing repair? HbA1c, glucose logs, nutrition assessment, medication list

7. Wound bed Is necrosis, biofilm, or an abnormal edge present? Tissue types, exudate, edge, response to debridement

8. Person and setting Can the patient carry out the plan? What are the goals? Function, cognition, social support, preferences

  • 9. Prognosis and plan How likely is healing, and what will change first? Synthesis of the above
  • Interpreting Common Data

Finding Usual Interpretation Watch For

ABI 0.9–1.3 Normal range Can be normal with severe distal disease; check waveforms and toe pressures in diabetes and kidney disease

ABI above about 1.3–1.4 Noncompressible, calcified arteries Obtain toe pressures, TBI, or TcPO2

Toe pressure below 30 mmHg or TcPO2 below 30 mmHg Severe ischemia with poor healing potential Urgent vascular referral

ESR above about 70 mm/h Strongly supports osteomyelitis in a diabetic foot ulcer Also elevated in other inflammatory conditions

Positive probe-to-bone test Supports osteomyelitis, especially when pretest probability is high A negative test helps rule out osteomyelitis in lower-risk patients

Normal radiograph Does not exclude early osteomyelitis (bone changes take about 2 weeks or more) Repeat radiographs or obtain MRI

Normal WBC, no fever Does not exclude serious diabetic foot infection Rely on local and systemic clinical signs

  • Low albumin Marker of illness severity and inflammation Not proof of malnutrition
  • HbA1c above target Poor recent glycemic control Falsely low with anemia, transfusion, or kidney failure
  • Recognizing Outliers

An outlier is a result or course that does not match the working diagnosis. Common examples:

A "venous" ulcer that fails compression: Recheck arterial status, look for mixed disease, and consider biopsy for malignancy, vasculitis, or pyoderma gangrenosum.

A diabetic foot ulcer that stalls despite offloading: Check whether the offloading is actually being used, look for osteomyelitis, and remeasure perfusion.

Pain far out of proportion: Consider calciphylaxis, pyoderma gangrenosum, vasculitis, necrotizing infection, or ischemia.

Wound enlarging after debridement: Consider pathergy from pyoderma gangrenosum or inadequate perfusion.

Unusual location or appearance: Rolled edges, exuberant tissue, or an ulcer in a non-pressure area deserves biopsy.

Prognosis

Prognosis combines wound factors (size, duration, depth, grade), perfusion, infection, and host factors. Staging systems help: the SVS WIfI system estimates amputation risk and benefit of revascularization, the University of Texas system adds infection and ischemia to depth, and SINBAD scores site, ischemia, neuropathy, bacterial infection, area, and depth. A 4-week percentage area reduction below roughly 50% for diabetic foot ulcers or 40% for venous leg ulcers signals a low chance of healing by 12 weeks with the current plan.

When several severe findings coexist, the probability of healing without major change is low. For example, a patient with an ABI of 0.4 and TcPO2 of 20 mmHg, uncontrolled diabetes, and very low albumin from chronic illness is very unlikely to heal a foot ulcer without intervention; the ischemia is the dominant barrier because no local therapy can overcome inadequate blood supply.

Choosing the Level of Care and Referrals

  • Situation Usual Level of Care
  • Mild infection, stable perfusion, capable self-care or support Outpatient wound clinic
  • Needs skilled dressing changes or NPWT and is homebound Home health
  • Needs daily skilled care or IV antibiotics and cannot manage at home Skilled nursing facility

Severe infection with systemic inflammatory signs, sepsis, rapidly progressive infection, or deep abscess Hospital admission and urgent surgery

Chronic limb-threatening ischemia with tissue loss or acute limb ischemia Urgent vascular surgery evaluation; admission if acute

Referrals follow the barriers: vascular surgery for ischemia, infectious diseases for complex or resistant infection, endocrinology for glycemic control, dermatology or rheumatology for atypical or inflammatory ulcers, nephrology for kidney-related wounds, dietitian, physical and occupational therapy, orthotics, social work, and palliative care.

Writing the Plan

State the etiology and the main barriers in order of importance.

List actions for each barrier, starting with the dominant one.

Set a measurable goal (for example, a 50% area reduction in 4 weeks) and a date to review it.

Document patient goals, education, and who is responsible for each step.

  • Clinical Traps
  • Trap 1: Treating the Wound Bed While Ignoring the Limb

Advanced dressings and skin substitutes cannot overcome a toe pressure of 20 mmHg. Fix perfusion first.

Trap 2: Accepting a Reassuring Number That Does Not Fit

A normal-looking ABI of 1.45 in a patient with dialysis-dependent kidney failure is a warning sign of calcified vessels, not proof of good circulation.